TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997
TCL Archive FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication November 18, 2011